Cholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.
Initially believed to be an acoustic attack, researchers now believe they have pinpointed a possible cause of the bizarre neurological symptoms reported by diplomats in Cuba in 2016. Researchers say a possible source for 'Havana syndrome' is exposure to cholinesterase inhibitors via organophosphorus insecticides.
Columbia researchers have identified a way in which to determine if a patient with MCI may respond to cholinesterase inhibitors.
Longer and more intense rehabilitation following stroke or TBI may produce greater benefits for recovery, a new study reports.
Researchers have discovered how cholinesterase inhibitors, a class of drug that prevents the breakdown of acetylcholine, could sharpen the brain's performance in patients with Alzheimer's disease.